Early research (Phase 1)Study completedNCT01379339What this trial is testingCabazitaxel - PF Induction ChemotherapyWho this might be right forSquamous Cell Carcinoma of the Head and Neck Krzysztof Misiukiewicz 40
Testing effectiveness (Phase 2)Study completedNCT00006471What this trial is testingFenretinide in Treating Patients With Recurrent or Metastatic Head and Neck CancerWho this might be right forHead and Neck Cancer M.D. Anderson Cancer Center 11
Testing effectiveness (Phase 2)Ended earlyNCT05265013What this trial is testingASP-1929 Photoimmunotherapy Combined With Pembrolizumab in Patients With Recurrent Head and Neck Cancer, With or Without MetastasesWho this might be right forHead and Neck Cancer Rakuten Medical, Inc. 16
Not applicableUnknownNCT03652142What this trial is testingPredictive Biomarkers for Response to Nivolumab in Head and Neck Squamous Cell CarcinomaWho this might be right forHNSCCDNA DamageDNA Double Strand Break Attikon Hospital 50
Testing effectiveness (Phase 2)Study completedNCT00248560What this trial is testingGemcitabine and Docetaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck CancerWho this might be right forHead and Neck Cancer Barbara Ann Karmanos Cancer Institute 36
Not applicableLooking for participantsNCT07054086What this trial is testingPatient Derived Organoids (PDOs) to Observe the Clinical Consistency of Personalized Neoadjuvant Therapy for Resectable Esophageal Squamous Cell CarcinomaWho this might be right forEsophageal Cancer Shanghai Zhongshan Hospital 30
Large-scale testing (Phase 3)Looking for participantsNCT06992427What this trial is testingHigh-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck CancerWho this might be right forHead and Neck Squamous Cell CarcinomaStage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8Stage II Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8+2 more Alliance for Clinical Trials in Oncology
Large-scale testing (Phase 3)Study completedNCT02923258What this trial is testingPostoperative CCRT With Docetaxel vs Cisplatin in High Risk Oral Cavity CancerWho this might be right forOral Cavity Squamous Cell Carcinoma Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University 224
Very early researchStudy completedNCT05678348What this trial is testingPyrimethamine as an Inhibitor of NRF2 in HPV-unrelated Locally Advanced Head and Neck Squamous Cell CarcinomaWho this might be right forHead and Neck CancerCancer of the Head and Neck Washington University School of Medicine 22
Testing effectiveness (Phase 2)Study completedNCT00589667What this trial is testingA Phase II Study of Pemetrexed Plus Gemcitabine for Metastatic/Recurrent Head and Neck Cancer (HNSCC)Who this might be right forHead and Neck Cancer Memorial Sloan Kettering Cancer Center 26
Not applicableStudy completedNCT00483821What this trial is testingA Retrospective Analysis of Neck Dissection Following Complete Response to Chemoradiation in HNSCCWho this might be right forHead and Neck Cancer Vanderbilt-Ingram Cancer Center 165
Testing effectiveness (Phase 2)Active Not RecruitingNCT04080804What this trial is testingStudy of Safety and Tolerability of Nivolumab Treatment Alone or in Combination With Relatlimab or Ipilimumab in Head and Neck CancerWho this might be right forHead and Neck Squamous Cell Carcinoma (HNSCC) Dan Zandberg 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT04074967What this trial is testingStudy of ARRY-614 Plus Either Nivolumab or Nivolumab+IpilimumabWho this might be right forRenal Cell CarcinomaMelanomaSolid Tumor+2 more Dan Zandberg 70
Not applicableNot Yet RecruitingNCT06599801What this trial is testingClinical Outcomes of Thoracodorsal Artery Flap in Oral and Maxillofacial ReconstructionWho this might be right forOral Squamous Cell Carcinoma (OSCC) Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 217
Early research (Phase 1)Looking for participantsNCT07217028What this trial is testingStudy Evaluating [18F]NOTA-ABY030 for Safety and Tolerability of Indeterminate Primary and/or Metastatic Disease in Head and Neck Squamous Cell CarcinomaWho this might be right forSCC - Squamous Cell CarcinomaRadiotracerHead and Neck Squamous Cell Carcinoma+1 more Vanderbilt-Ingram Cancer Center 25
Very early researchStudy completedNCT04188665What this trial is testingUsing MASL to Combat Oral CancerWho this might be right forSquamous Cell Carcinoma of Head and Neck Rowan University 18
Testing effectiveness (Phase 2)Study completedNCT01133665What this trial is testingCetuximab and Lenalidomide in Head and NeckWho this might be right forSquamous Cell Carcinoma University of Chicago 42
Not applicableEnrolling By InvitationNCT06863831What this trial is testingTrial of YSQTG vs. Simulated Agents With Neoadjuvant Chemoradiotherapy or Chemoimmunotherapy for ECWho this might be right forEsophageal Squamous Cell Carcinoma (ESCC) Cancer Institute and Hospital, Chinese Academy of Medical Sciences 536
Not applicableStudy completedNCT01466257What this trial is testingBiomarkers in Patients With Head and Neck CancerWho this might be right forHead and Neck Cancer ECOG-ACRIN Cancer Research Group 70
Testing effectiveness (Phase 2)Ended earlyNCT03361228What this trial is testingEvaluate the Safety, Tolerability, and Antitumor Activity of INCB001158 Plus Epacadostat, With or Without Pembrolizumab, in Advanced Solid TumorsWho this might be right forSolid Tumors Incyte Corporation 5